Two Church lab vets, a se­cre­tive in­sti­tute and an Is­raeli bil­lion­aire hunt for drugs in the guts of wild an­i­mals

5 years ago
Startups
Discovery

EMA: On­go­ing study da­ta of Cell­tri­on’s mAb enough to al­low its use in some Covid-19 pa­tients

5 years ago
FDA+
Coronavirus

With an­oth­er $148M in the bank, Gy­ro­scope Ther­a­peu­tics looks to hus­tle its AMD gene ther­a­py through mid-stage tests

5 years ago
Financing

Hun­ker­ing down on deals and racial di­ver­si­ty pledge amid pan­dem­ic, Gio­van­ni Caforio took home $20M last year at ...

5 years ago
People

An­oth­er 4 phar­mas make the fa­bled Nas­daq leap, with com­bined raise rapid­ly ap­proach­ing $4.5B

5 years ago
Financing

Covid-19 roundup: Cuo­mo ad­min­is­tra­tion al­leged­ly gave Re­gen­eron's George Yan­copou­los spe­cial pref­er­ence for test­ing ...

5 years ago
Coronavirus

Chi­nese CD­MO Ray­bow quadru­ples work­force at NC site, hop­ing to help build next bio­phar­ma man­u­fac­tur­ing hub

5 years ago
R&D
Manufacturing

From an­tipasti to an­tivi­rals: Ginkgo's qui­et quest to re­make how mR­NA vac­cines are made

5 years ago
Manufacturing

No­var­tis walks away from 3rd Zol­gens­ma plant just a year af­ter leas­ing it as it piv­ots re­sources to next-gen pipeline

5 years ago
Pharma
Manufacturing

FDA ex­pert pan­el lines up 19-to-1 against Pfiz­er’s os­teoarthri­tis drug tanezum­ab

5 years ago
Pharma
FDA+

Covid-19 man­u­fac­tur­ing roundup: As­traZeneca de­nies stock­pil­ing claims; Vir­chow Biotech to make Sput­nik V vac­cine in ...

5 years ago
Manufacturing

SEC opens in­quiry in­to Wall Street's SPAC ma­nia — re­port; A Chi­na-based gene ther­a­py play­er now has $80M more in ...

5 years ago
News Briefing

Broad In­sti­tute opens new $300M cen­ter to an­swer 1 ques­tion: What's pos­si­ble when you ap­ply ma­chine learn­ing to ...

5 years ago
Pharma

Is a 'su­per-sea­son­al' flu vac­cine on the hori­zon? The NIH and UW are tak­ing a shot in­to the clin­ic this April

5 years ago
Discovery

US to no longer dis­trib­ute Eli Lil­ly’s bam­lanivimab alone due to coro­n­avirus vari­ants

5 years ago
Pharma
FDA+

HHS in­spec­tor gen­er­al signs off on No­var­tis pay­ing for pricey Kym­ri­ah

5 years ago
Pharma
FDA+

Bris­tol My­ers Squibb out­races the pack to a late-stage tri­al win for its LAG-3/PD-1 an­ti­body com­bo in melanoma

5 years ago
R&D
Pharma

GV wa­gers on sea­soned team's in­tranasal 'tem­po­rary' pre­ven­ta­tive ap­proach to virus­es — with ex-Gilead CEO John ...

5 years ago
Financing
Startups

River­Vest off to the races with $275M to in­vest in ear­ly-stage biotech

5 years ago
Financing

Covid-19 roundup: In­dia halts As­traZeneca vac­cine ex­ports as in-coun­try cas­es rise — re­port

5 years ago
Coronavirus

Fol­low­ing the flow of the biotech in­dus­try, La­va heads to Nas­daq with a gam­ma delta T cell promise

5 years ago
Financing

FDA adds Guil­lain-Bar­ré syn­drome warn­ing to Glax­o­SmithK­line’s shin­gles vac­cine

5 years ago
Pharma
FDA+

T cell ther­a­py play­er Lyell pre­pares to open $65M man­u­fac­tur­ing fa­cil­i­ty in the Seat­tle area

5 years ago
Manufacturing

Neu­ro up­start launch­es out of RA Cap­i­tal’s low-pro­file in­cu­ba­tor with Big Phar­ma vets, clin­i­cal drugs and $80M

5 years ago
Financing
Startups
First page Previous page 726727728729730731732 Next page Last page
A service from the Financial Times